Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,903.50 -9.50 (-0.50%)

Bid:

1,904.00

Ask:

1,905.00

Spread: 1.00 (0.053%)

Market Cap: £76.34b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

GSK meningococcal vaccine receives EMA recommendation

(Sharecast News) - Pharmaceutical and biotechnology company GSK said on Tuesday that the European Medicine Agency has recommended meningococcal vaccin...

TOP NEWS: GSK celebrates positive EU opinion of liquid Menveo vaccine

(Alliance News) - GSK PLC on Tuesday announced a new positive opinion from the EU's European Medicine Agency's Committee for Medicinal Products for Hu...

LONDON BRIEFING: Smiths raises dividend, CRH gives CFO top job

(Alliance News) - The FTSE 100 was called higher on Tuesday morning, ahead of US consumer confidence data and following news that Australia's central ...

Boehringer Ingelheim faces second hung jury in Chicago Zantac trial

Hung jury in latest Zantac cancer trial in Chicago *

A second Zantac cancer trial ends with hung jury

Hung jury in latest Zantac cancer trial in Chicago *

GSK reaches further two settlements regarding Zantac

(Alliance News) - GSK PLC on Wednesday said it reached two confidential settlements regarding the Zantac case in California State Court.

GSK settles two Zantac cases in California

(Sharecast News) - GSK announced on Wednesday that it has reached confidential settlements in two lawsuits filed in California State Court related to ...

GSK says Blenrep combinations accepted for review in Japan

(Alliance News) - GSK PLC on Tuesday said its Blenrep cancer treatment will undergo review in Japan after successful authorisations recently in the UK...